[Role of physiologically active substances in the pathogenesis and therapy of atherosclerosis].
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D002219:Carbamates / Q000627:therapeutic use*; D002807:Chondroitin / Q000031:analogs & derivatives*; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D008798:Mevalonic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011727:Pyridinolcarbamate / Q000031:analogs & derivatives / Q000627:therapeutic use*; D011817:Rabbits
D002219:Carbamates; D011727:Pyridinolcarbamate; D002807:Chondroitin; D002809:Chondroitin Sulfates; D008798:Mevalonic Acid
Rol' fiziologicheski aktivnykh veshchestv v patogeneze i terapii ateroskleroze